Signaling through receptors and scaffolds: independent interactions reduce combinatorial complexity.

After activation, many receptors and their adaptor proteins act as scaffolds displaying numerous docking sites and engaging multiple targets. The consequent assemblage of a variety of protein complexes results in a combinatorial increase in the number of feasible molecular species presenting different states of a receptor-scaffold signaling module. Tens of thousands of such microstates emerge even for the initial signal propagation events, greatly impeding a quantitative analysis of networks. Here, we demonstrate that the assumption of independence of molecular events occurring at distinct sites enables us to approximate a mechanistic picture of all possible microstates by a macrodescription of states of separate domains, i.e., macrostates that correspond to experimentally verifiable variables. This analysis dissects a highly branched network into interacting pathways originated by protein complexes assembled on different sites of receptors and scaffolds. We specify when the temporal dynamics of any given microstate can be expressed using the product of the relative concentrations of individual sites. The methods presented here are equally applicable to deterministic and stochastic calculations of the temporal dynamics. Our domain-oriented approach drastically reduces the number of states, processes, and kinetic parameters to be considered for quantification of complex signaling networks that propagate distinct physiological responses.

[1]  D. Gillespie Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .

[2]  R Heinrich,et al.  Metabolic regulation and mathematical models. , 1977, Progress in biophysics and molecular biology.

[3]  A. Cornish-Bowden Fundamentals of Enzyme Kinetics , 1979 .

[4]  A. Perelson Receptor clustering on a cell surface. I. theory of receptor cross-linking by ligands bearing two chemically identical functional groups , 1980 .

[5]  J. Olefsky,et al.  Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP. , 1994, The Journal of biological chemistry.

[6]  B. Goldstein,et al.  The kinetics of bivalent ligand-bivalent receptor aggregation: ring formation and the breakdown of the equivalent site approximation. , 1995, Mathematical biosciences.

[7]  C. Roberts,et al.  Interaction between the Insulin Receptor and Its Downstream Effectors , 1996, The Journal of Biological Chemistry.

[8]  J. Blenis,et al.  YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites , 1996, Molecular and cellular biology.

[9]  James E. Ferrell,et al.  Mechanistic Studies of the Dual Phosphorylation of Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.

[10]  J. Tikerpae,et al.  An evaluation of the cross-linking model for the interaction of insulin with its receptor. , 1997, The American journal of physiology.

[11]  K. Siddle,et al.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. , 1998, The Biochemical journal.

[12]  D. Bray,et al.  Predicting temporal fluctuations in an intracellular signalling pathway. , 1998, Journal of theoretical biology.

[13]  B. Kholodenko,et al.  Control analysis of metabolic systems involving quasi-equilibrium reactions. , 1998, Biochimica et biophysica acta.

[14]  M. Gold,et al.  The Gab1 Protein Is a Docking Site for Multiple Proteins Involved in Signaling by the B Cell Antigen Receptor* , 1998, The Journal of Biological Chemistry.

[15]  Alan Wells,et al.  Effect of Epidermal Growth Factor Receptor Internalization on Regulation of the Phospholipase C-γ1 Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[16]  D. Lauffenburger,et al.  Internalized Epidermal Growth Factor Receptors Participate in the Activation of p21 ras in Fibroblasts* , 1999, The Journal of Biological Chemistry.

[17]  B. Kholodenko,et al.  Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[18]  C. Yip,et al.  Mechanism of Transmembrane Signaling: Insulin Binding and the Insulin Receptor† , 2000 .

[19]  D. Müller-Wieland,et al.  Identification of major tyrosine phosphorylation sites in the human insulin receptor substrate Gab-1 by insulin receptor kinase in vitro. , 2000, Biochemistry.

[20]  Joseph Schlessinger,et al.  A Novel Positive Feedback Loop Mediated by the Docking Protein Gab1 and Phosphatidylinositol 3-Kinase in Epidermal Growth Factor Receptor Signaling , 2000, Molecular and Cellular Biology.

[21]  Ping-yuan Wang,et al.  Presence of Oxidized Cholesterol in Caveolae Uncouples Active Platelet-derived Growth Factor Receptors from Tyrosine Kinase Substrates* , 2000, The Journal of Biological Chemistry.

[22]  T. Hunter,et al.  Signaling—2000 and Beyond , 2000, Cell.

[23]  Jehoshua Bruck,et al.  Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Dennis Bray,et al.  Molecular model of a lattice of signalling proteins involved in bacterial chemotaxis , 2000, Nature Cell Biology.

[25]  Nicolas Le Novère,et al.  STOCHSIM: modelling of stochastic biomolecular processes , 2001, Bioinform..

[26]  T Pawson,et al.  SH2 domains, interaction modules and cellular wiring. , 2001, Trends in cell biology.

[27]  Yu Zhao,et al.  The Mechanism of Dephosphorylation of Extracellular Signal-regulated Kinase 2 by Mitogen-activated Protein Kinase Phosphatase 3* , 2001, The Journal of Biological Chemistry.

[28]  A. J. Ablooglu,et al.  Activation of the insulin receptor's kinase domain changes the rate-determining step of substrate phosphorylation. , 2001, Biochemistry.

[29]  C. Rao,et al.  Control, exploitation and tolerance of intracellular noise , 2002, Nature.

[30]  M. White,et al.  IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[31]  A. Saltiel,et al.  Insulin signaling pathways in time and space. , 2002, Trends in cell biology.

[32]  C. Heldin,et al.  SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF β-receptor , 2002, Oncogene.

[33]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[34]  B. Neel,et al.  Receptor-Specific Regulation of Phosphatidylinositol 3′-Kinase Activation by the Protein Tyrosine Phosphatase Shp2 , 2002, Molecular and Cellular Biology.

[35]  J. Whittaker,et al.  Structural biology of insulin and IGF1 receptors: implications for drug design , 2002, Nature Reviews Drug Discovery.

[36]  B. Kholodenko,et al.  Temperature dependence of the epidermal growth factor receptor signaling network can be accounted for by a kinetic model. , 2002, Biochemistry.

[37]  T. Hirano,et al.  Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2 , 2003, Oncogene.

[38]  James R Faeder,et al.  The complexity of complexes in signal transduction , 2003, Biotechnology and bioengineering.

[39]  T. Hirano,et al.  The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors , 2003, Cancer science.

[40]  Hiroaki Kitano,et al.  Next generation simulation tools: the Systems Biology Workbench and BioSPICE integration. , 2003, Omics : a journal of integrative biology.

[41]  Youping Deng,et al.  Growth Factor Receptor-binding Protein 10 (Grb10) as a Partner of Phosphatidylinositol 3-Kinase in Metabolic Insulin Action* , 2003, Journal of Biological Chemistry.

[42]  E. Nagata,et al.  Akt as a mediator of cell death , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Blundell,et al.  The structural biology of growth factor receptor activation. , 2002, Biophysical chemistry.

[44]  Chi-Hung Cheng,et al.  Src Phosphorylates Grb2-associated Binder 1 upon Hepatocyte Growth Factor Stimulation* , 2003, Journal of Biological Chemistry.

[45]  S. Kimura,et al.  A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. , 2003, The Biochemical journal.

[46]  C. Mounier,et al.  Epidermal Growth Factor-induced DNA Synthesis , 2003, The Journal of Biological Chemistry.

[47]  M. Hayman,et al.  Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling , 2003, Molecular and Cellular Biology.

[48]  W. S. Hlavacek,et al.  Investigation of Early Events in FcεRI-Mediated Signaling Using a Detailed Mathematical Model1 , 2003, The Journal of Immunology.

[49]  B. Kholodenko,et al.  Control theory of metabolic channelling , 1994, Molecular and Cellular Biochemistry.

[50]  M. White,et al.  The IRS-signalling system: A network of docking proteins that mediate insulin action , 1998, Molecular and Cellular Biochemistry.

[51]  W. S. Hlavacek,et al.  Mathematical and computational models of immune-receptor signalling , 2004, Nature Reviews Immunology.

[52]  B. Kholodenko,et al.  Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades , 2004, The Journal of cell biology.

[53]  William S. Hlavacek,et al.  BioNetGen: software for rule-based modeling of signal transduction based on the interactions of molecular domains , 2004, Bioinform..

[54]  B N Kholodenko,et al.  Signal processing at the Ras circuit: what shapes Ras activation patterns? , 2004, Systems biology.

[55]  Roger Brent,et al.  Automatic generation of cellular reaction networks with Moleculizer 1.0 , 2005, Nature Biotechnology.